San Diego-based Shoreline Biosciences, a developer of cell immunotherapies for treating solid tumors and hematologic malignancies, has raised $140M in a financing round, the company said today. The fu
San Diego-based Model Medicines, a company that is developing artificial intelligence and machine learning software for the drug discovery and development process, has raised $4.1M in a funding roun